Cytogenetic and molecular genetic abnormalities in agnogenic myeloid metaplasia

Seminars in Oncology

Volumn 32, Issue 4, 2005, Pages 359-364

  Reilly, John T ^a  

^a Academic Unit of Haematology   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ISOPROTEIN; PROTEIN P53;

AGE DISTRIBUTION; ANDROGEN THERAPY; ARTICLE; CHROMOSOME 1; CHROMOSOME 13; CHROMOSOME 13Q; CHROMOSOME 20; CHROMOSOME 20Q; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME 9; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CYTOGENETICS; DIAGNOSTIC PROCEDURE; GENE TARGETING; GENE TRANSLOCATION; GENETIC DISORDER; GENETIC SCREENING; HUMAN; INCIDENCE; KARYOTYPE; LEUKEMIA; MOLECULAR CLONING; MOLECULAR GENETICS; MYELOID METAPLASIA; ONCOGENE; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; TRISOMY 8;

CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; CHRONIC DISEASE; DNA MUTATIONAL ANALYSIS; HUMANS; KARYOTYPING; MYELOFIBROSIS; MYELOID METAPLASIA;

EID: 23044463668     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2005.04.007     Document Type: Article

References (93)

1. R.J. Jacobson, A. Salo, P.J. Fialkow Agnogenic myeloid metaplasia: A clonal proliferation of haematopoietic stem cells with secondary myelofibrosis Blood 51 1978 189 194
2. G.S. Lucas, R.A. Padua, G.S. Masters The application of X chromosome gene probes to the diagnosis of myeloproliferative disease Br J Haematol 72 1989 530 533
3. K.M. Taylor, M. Shetta, M. Talpaz Myeloproliferative disorders: Usefulness of X-linked probes in diagnosis Leukemia 3 1989 419 422
4. B. Anger, J.W. Janssen, H. Schrezenmeier Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms Leukemia 4 1990 258 261
5. H. Kreipe, K. Jaquet, J. Felgner Clonal granulocytes and marrow cells in the cellular phase of agnogenic myeloid metaplasia Blood 78 1991 1814 1817
6. R.E. Gale, H. Wheadon, P. Boulos Tissue specificity of X-chromosome inactivation patterns Blood 83 1994 2899 2905
7. N. Tsukamoto, K. Morita, T. Maehara Clonality in chronic myeloproliferative disorders defined by X-chromosome linked probes: Demonstration of heterogeneity in lineage involvement Br J Haematol 86 1994 253 258
8. F.A. Asimakopoulos, J.G. Gilbert, M.A. Aldred Interstitial deletion constitutes the major mechanism for loss of heterozygosity on chromosome 20q in polycythemia vera Blood 88 1996 2690 2698
9. M. Buschle, J.W. Janssen, H. Drexler Evidence for pluripotential stem cell origin of idiopathic myelofibrosis: Clonal analysis of a case characterised by a N-ras gene mutation Leukemia 2 1988 658 660
10. T.L. Reeder, R.J. Bailey, G.W. Dewald Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia Blood 101 2003 1981 1983
11. J.C. Wang, H.D. Lang, S. Lichter Cytogenetic studies of bone marrow fibroblasts cultured from patients with myelofibrosis and myeloid metaplasia Br J Haematol 80 1992 184 188
12. H. Castro-Malaspina, R.E. Gay, S.L. Thanwar Characteristics of bone marrow fibroblast colony forming cells and their progeny in patients with myeloproliferative disorders Blood 59 1982 1046 1056
13. P. Guardiola, H. Esperou, D. Cazals-Hatem Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia Br J Haematol 98 1997 1004 1009
14. J.T. Reilly Idiopathic myelofibrosis: Pathogenesis, natural history and management Blood Rev 11 1997 233 242
15. B. Zhang, S.M. Lewis The splenomegaly of myeloproliferative and lymphoproliferative disorders: Splenic cellularity and vascularity Eur J Haematol 43 1989 63 66
16. R.A. Mesa, C.Y. Li, G. Schroeder Clinical correlates of splenic histopathology and splenic karyotype in myelofibrosis with myeloid metaplasia Blood 97 2001 3665 3667
17. J.T. Reilly, J.A. Snowden, R.L. Spearing Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: A study of 106 cases Br J Haematol 98 1997 96 102
18. J.L. Demory, B. Dupriez, P. Fenaux Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: A report on 47 cases Blood 72 1988 855 859
19. A. Tefferi, R.A. Mesa, G. Schroeder Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia Br J Haematol 113 2001 763 771
20. A.J. Bench, E.P. Nacheva, K.M. Champion Molecular genetics and cytogenetics of myeloproliferative disorders Baillieres Clin Haematol 11 1998 819 848
21. B. Dupriez, P. Morel, J.-L. Demory Prognostic factors in agnogenic myeloid metaplasia: A report on 195 cases with a new scoring system Blood 88 1996 1013 1018
22. J.T. Reilly, J. Wilson, D. Barnett Karyotypic and ras gene mutation analysis in idiopathic myelofibrosis Br J Haematol 88 1994 575 581
23. U. Trautmann, A. Rubbert, M. Gramatzki Multiple chromosomal changes and karyotypic evolution in a patient with myelofibrosis Cancer Genet Cytogenet 61 1992 6 10
24. S. Kerim, G. Rege-Cambrin, P. Scaravaglio Trisomy 8 and unbalanced t(5;17)(q11;p11) charcterise two karyotypically independent clones in a case of idiopathic myelofibrosis evolving to acute nonlymphoid leukemia Cancer Genet Cytogenet 52 1991 63 69
25. F. Cervantes, G. Barosi, J.-L. Demory Myelofibrosis with myeloid metaplasia in young individuals: Disease charcteristics, prognostic factors and identification of risk groups Br J Haematol 102 1998 684 690
26. F. Cervantes, G. Barosi, J.-C. Hernández-Boluda Myelofibrosis with myeloid metaplasia in adult individuals 30 years old or younger: Presenting features, evolution and survival Eur J Haematol 66 2001 324 327
27. R.A. Altura, D.R. Head, W.C. Wang Long-term survival of infants with idiopathic myelofibrosis Br J Haematol 109 2000 459 462
28. J.D. Rowley Abnormalities of chromosome no 1 in haematological malignancies Lancet 1 1978 554 555
29. G. Gahrton, K. Friburg, J. Lindsten Duplication of part of the long arm of chromosome 1 in myelofibrosis terminating in acute myeloblastic leukemia Hereditas 88 1978 1 5
30. E. Donti, A. Tabilio, F. Bocchini Partial trisomy 1q in idiopathic myelofibrosis Leuk Res 14 1990 1035 1040
31. B. Zanke, J. Squire, H. Griesser A hematopoietic protein tyrosine phosphatse (hePTP) gene that is amplified and overexpressed in myeloid malignancies maps to chromosome 1q32. 1 Leukemia 8 1994 236 244
32. R.S. Verma, N.G. Triantafillou Oncogenetic map of human genome Cancer Genet Cytogenet 100 1998 88 90
33. J.P.M. Geraedts, G.J. den Ottolander, J.E. Ploem An identical translocation between chromosome 1 and 7 in three patients with myelofibrosis and myeloid metaplasia Br J Haematol 44 1980 569 575
34. G. Rege-Cambrin, F. Speleman, S. Kerim Extra translocation +der(1q9p) is a prognostic indicator in myeloproliferative disorders Leukemia 5 1991 1059 1063
35. T.S.K. Wan, S.K. Ma, W.Y. Au Derivative (1;18)(q10;q10): A recurrent and novel unbalanced tranlocation involving 1q in myeloid disorders Cancer Genet Cytogenet 128 2001 35 38
36. J. Andrieux, J.L. Demory, M.T. Caulier Karyotypic abnormalities in myelofibrosis following polycythemia vera Cancer Genet Cytogenet 140 2003 118 123
37. P. Liebisch, C. Wendl, A. Wellmann High incidence of trisomies 1q, 9q, and 11q in multiple myeloma: Results from a comprehensive molecular cytogenetic analysis Leukemia 17 2003 2535 2537
38. G.W. Dewald, C.R. Schad, V.C. Lilla Frequency and photographs of HGM11 chromosomal anomalies in bone marrow samples from 3,996 patients with malignant hematologic neoplasms Cancer Genet Cytogenet 68 1993 60 69
39. F. Solé, J. Maria de Pablos, S. Woessner Coexistence of tetrasomy 8 and trisomy 8 in a case with myeloid metaplasia with myelofibrosis Cancer Genet Cytogenet 94 1997 147 150
40. E. Nacheva, C. grace, T.L. Holloway Comparative genomic hybridization in acute myeloid leukemia: A comparison with G-banding and chromosomal painting Cancer Genet Cytogenet 82 1995 9 16
41. D.W. Hammond, R. Brown, G.A. Wilson Gains on the short arm of chromosome 9 are common in idiopathic myelofibrosis: A comparative genomic hybridisation study Blood 102 2003 147a (abstr)
42. B. Swolin, A. Weinfeld, A. Westin A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical course Blood 72 1988 386 395
43. Z. Chen, M. Notohamiprodjom, X.-Y. Guan Gain of 9p in the pathogenesis of polycythemia vera Genes Chromosomes Cancer 22 1998 321 324
44. V. Najfeld, L. Montella, A. Scalise Exploring polycythaemia vera with fluorescence in situ hydridisation: Additional cryptic 9p is the most frequent abnormality detected Br J Haematol 119 2002 558 566
45. N.B. Westwood, A.M. Gruszka-Westwood, S. Atkinson Polycythaemia vera: Analysis of DNA from blood granulocytes using comparative genomic hybridisation Haematologica 86 2001 464 469
46. C.M. Morris, J.M. Cochrane, S.M. Benjes Molecular definition of interstitial deletions of chromosome 13 in leukemia cells Cancer Genet Cytogenet 3 1991 455 460
47. K. Tanaka, M. Arif, M. Eguchi Frequent allelic loss of the RB, D13S319 and D13S25 locus in myeloid malignancies with deletion/translocation at 13q14 of chromosome 13, but not in lymphoid malignancies Leukemia 13 1999 1367 1373
48. E.J. Sinclair, E.C. Forrest, J.T. Reilly Fluorescence in situ hybridization analysis of 25 cases of idiopathic myelofibrosis and two cases of secondary myelofibrosis: Monoallelic loss of RB1, D13S319 and D13S25 loci associated with cytogenetic deletions and translocations involving 13q14 Br J Haematol 113 2001 365 368
49. R. La Starza, I. Wlodarska, A. Aventin Molecular delineation of 13q deletion boundaries in 20 patients with myeloid malignancies Blood 91 1998 231 237
50. A.L. Juneau, M. Kaehler, E.R. Christensen Detection of RB1 deletions by fluorescence in situ hybridization in malignant hematologic disorders Cancer Genet Cytogenet 103 1998 117 123
51. A.C. Gardiner, M.M. Corcoran, D.G. Oscier Cytogenetic fluorescence in situ hybridization and clinical evaluation of translocations with concomitant deletion of 13q14 in chronic lymphocytic leukemia Genes Chromosomes Cancer 20 1997 73 81
52. D.H.C. MacDonald, D. Lairi, A. Chase A case of myelofibrosis with a t(4;13)(q25;q12): evidence for involvement of a second 13q12 locus in chronic myeloproliferative disorders Br J Haematol 105 1999 771 774
53. L.Y. Hsu, M.L. Greenberg, S. Kohan Trisomy 13 in bone marrow cells in acute myelocytic leukemia and myelofibrosis Clin Genet 15 1979 327 331
54. F. Ferrara, L. Vicari, B. Festa Trisomy 13 in a case of myelofibrosis with myeloid metaplasia with early blastic transformation Haematologica 80 1995 434 436
55. N. Zojer, J.G. Meran, M. Vesely Trisomy 13 associated with poor prognosis in idiopathic myelofibrosis with myeloid metaplasia Leuk Lymph 35 1999 415 421
56. F. Mertens, B. Johansson, S. Heim Karyotypic patterns in chronic myeloproliferative disorders: Report of 74 cases and review of the literature Leukemia 5 1991 214 220
57. P.E. Hollings, I. Rosman, M.E.J. Beard A 20q deletion originating in a pluripotent stem cell Blood 83 1994 305 306
58. A.J. Bench, E.P. Nacheva, T.L. Hood Chromosome 20 deletions in myeloid malignancies: Reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes UK Cancer Cytogenetics Group (UKCCG). Oncogene 19 2000 3902 3913
59. D. MacGrogan, S. Alvarez, T. DeBlasio Identification of candidate genes on chromosome band 20q12 by physical mapping of translocation breakpoints found in myeloid leukemia cell lines Oncogene 20 2001 4150 4160
60. S. Borrego, G. Antinolo, A. Martin-Noya Translocation (8;12) in a patient with agnogenic myeloid metaplasia Cancer Genet Cytogenet 71 1993 183 184
61. D. Przepiorka, E. Brynat, P. Kidd Idiopathic myelofibrosis in blast transformation with 4;12 and 5;12 translocations and a 7q deletion Cancer Genet Cytogenet 30 1988 139 144
62. J.L. Huret, A. Brizard, S. Briasult Two additional cases of inv(12) in human malignancies Cancer Genet Cytogenet 32 1988 309 311
63. J. Andrieux, J.L. Demory, P. Morel (2002) Frequency of structural abnormalities of the long arm of chromosome 12 in myelofibrosis with myeloid metaplasia Cancer Genet Cytogenet 137 2002 68 71
64. J. Andrieux, J.L. Demory, B. Dupriez Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia Genes Chromosomes Cancer 39 2004 82 87
65. F.C. Besa, P.C. Nowell, N.L. Geller Analysis of the androgen response of 23 patients with agnogenic myeloid metaplasia: The value of chromosome studies predicting repsonse and survival Cancer 49 1982 308 313
66. S. Kasahara, H. Tsurumi, T. Hara Idiopathic myelofibrosis developing isolated sarcoma with der(1;7)(q10;p10) after splenectomy and finally transforming to acute myelogenous leuemia Leuk Lymphoma 39 2000 427 433
67. M.C. Cox, P. Panetta, A. Venditti New reciprocal translocation t(6;10)(q27;q11) associated with idiopathic myelofibrosis Leuk Res 25 2001 349 351
68. W.N. Patton, C.M. Bunce, S. Larkin Defective erythropoiesis in primary myelofibrosis associated with a chromosome 11 abnormality Br J Cancer 64 1991 128 131
69. S. Giraudier, H. Chagraoui, E. Komura Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors Blood 100 2002 2932 2940
70. + cells from patients with myelofibrosis with myeloid metaplasia using oligonucleotide microarrays Blood 98 2001 626a (abstr)
71. A.M. Vannucchi, L. Bianchi, C. Cellai Development of myelofibrosis in mice impaired for GATA-1 expression (GATA-1 (low) mice) Blood 100 2002 1123 1132
72. A.M. Vannucchi, L. Bianchi, A.R. Migliaccio Reduced GATA-1 content in megakaryocytes of patients with idiopathic myelofibrosis Blood 102 2003 663a (abstr)
73. M.-C. Martyre, V. Steunou, M.-C. LeBousse-Kerdiles Lack of alteration in GATA-1 expression in CD34+ hematopoietic progenitors from patients with idiopathic myelofibrosis Blood 101 2003 5087 5089
74. V. Steunou, M.C. Le Bousse-Kerdilš, A. Colin-Micouin Altered transcription of the stem cell leukemia gene in myelofibrosis with myeloid metaplasia Leukemia 17 2002 1998 2006
75. M. Valtieri, A. Tocci, M. Gabbianelli Enforced TAL-1 expression stimulates primitive erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program Cancer Res 58 1998 562 569
76. N.J. Elwood, H. Zogos, D.S. Pereira Enhanced megakaryocyte and erythroid development from normal human CD34+ cells: Consequence of enforced expression of SCL Blood 10 1998 3756 3765
77. J.W.G. Janssen, A.C.M. Steenvoorden, J. Lyons Ras gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders and myelodysplastic syndromes Proc Natl Acad Sci U S A 84 1987 9228 9232
78. S. Tsurumi, Y. Nakamura, K. Maki N-ras and p53 mutations in Japanese patients with myeloproliferative disorders Am J Hematol 71 2002 131 133
79. J.C. Wang, C. Chen N-RAS oncogene mutations in patients with agnogenic myeloid metaplasia in leukemic transformation Leuk Res 22 1998 639 643
80. G. Gaidano, A. Guerrasio, A. Serra Mutations in the p53 and ras family genes are associated with tumour progression of bcr/abl negative chronic myeloproliferative disorders Leukemia 7 1993 946 953
81. J.C. Wang, C. Chen p16 gene deletions and point mutations in patients with agnogenic myeloid metaplasia (AMM) Leuk Res 23 1999 631 635
82. A.R. Moliterno, W.D. Hankins, J.L. Spivak Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera N Engl J Med 338 1998 572 580
83. A.L. Taksin, J.P. Couedic, I. Dusanter-Fourt Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutations or to an autocrine stimulation by Mpl-L Blood 93 1999 125 139
84. J.C. Wang, W. Chen, S. Nallusamy Hypermethylation of the P15INK4b and P16INK4a in agnogenic myeloid metaplasia (AMM) and AMM in leukemic transformation Br J Haematol 116 2002 582 586
85. T. Siitonen, E.R. Savolainen, P. Koistinen Expression of the c-kit proto-oncogene in myeloproliferative disorders and myelodysplastic syndromes Leukemia 8 1994 631 637
86. T. Siitonen, A. Zheng, E.-R. Savolainen Spontaneous granulocyte- macrophage colony growth by peripheral blood monoclear cells in myeloproliferative disorders Leuk Res 20 1996 187 195
87. Y. Nakata, A. Kimura, O. Katoh c-kit point mutation of extracellular domain in patients with myeloproliferative disorders Br J Haematol 91 1995 661 663
88. A. Kimura, Y. Nakata, O. Katoh c-kit mutations in patients with myeloproliferative disorders Leuk Lymphoma 25 1997 81 287
89. F.M. Abu-Duhier, A.C. Goodeve, R. Care Mutational analysis of class III receptor tyrosine kinases (C-KIT, C-FMS, FLT3) in idiopathic myelofibrosis Br J Haematol 120 2003 464 470
90. T. van Daalen Wetters, S.A. Hawkins, M.F. Rousell Random mutagenesis of CSF-1 receptor (FMS) reveals multiple sites for activating mutations within the extracellular domain EMBO J 11 1992 551 557
91. F.M. Abu-Duhier, A.C. Goodeve, G.A. Wilson c-FMS mutational analysis in acute myeloid leukaemia Br J Haematol 123 2003 749 750
92. L.M. Kelly, Q. Liu, J.L. Kutok FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce a myeloproliferative disease in a murine bone marrow transplant model Blood 99 2002 310 318
93. F.M. Abu-Duhier, A.C. Goodeve, G.A. Wilson FLT3 internal tandem duplication mutations are rare in agnogenic myeloid metaplasia Blood 100 2002 364